These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26298354)

  • 1. Absorb bioresorbable vascular scaffold: What have we learned after 5 years of clinical experience?
    Caiazzo G; Kilic ID; Fabris E; Serdoz R; Mattesini A; Foin N; De Rosa S; Indolfi C; Di Mario C
    Int J Cardiol; 2015 Dec; 201():129-36. PubMed ID: 26298354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioresorbable vascular scaffold in patients with complex coronary artery disease.
    Tamburino CI; Capranzano P; Longo G; Immè S; Tamburino G; Scalia M; Condorelli A; Francaviglia B; LA Manna A; Sgroi C; Grasso C; DI Salvo ME; Capodanno D; Tamburino C
    Minerva Cardioangiol; 2016 Aug; 64(4):481-6. PubMed ID: 27128353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a fully bioresorbable vascular scaffold in patients with coronary artery disease: design of and rationale for the ABSORB III randomized trial.
    Kereiakes DJ; Ellis SG; Popma JJ; Fitzgerald PJ; Samady H; Jones-McMeans J; Zhang Z; Cheong WF; Su X; Ben-Yehuda O; Stone GW
    Am Heart J; 2015 Oct; 170(4):641-651.e3. PubMed ID: 26386787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design.
    Diletti R; Serruys PW; Farooq V; Sudhir K; Dorange C; Miquel-Hebert K; Veldhof S; Rapoza R; Onuma Y; Garcia-Garcia HM; Chevalier B
    Am Heart J; 2012 Nov; 164(5):654-63. PubMed ID: 23137495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trials.
    Muramatsu T; Onuma Y; van Geuns RJ; Chevalier B; Patel TM; Seth A; Diletti R; García-García HM; Dorange CC; Veldhof S; Cheong WF; Ozaki Y; Whitbourn R; Bartorelli A; Stone GW; Abizaid A; Serruys PW; ; ; ; ; ;
    JACC Cardiovasc Interv; 2014 May; 7(5):482-93. PubMed ID: 24746650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Everolimus-eluting Bioresorbable Vascular Scaffold Implantation in Real World and Complex Coronary Disease: Procedural and 30-day Outcomes at Two Australian Centres.
    Robaei D; Back LM; Ooi SY; Pitney MR; Jepson N
    Heart Lung Circ; 2015 Sep; 24(9):854-9. PubMed ID: 25778622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioresorbable vascular scaffolds for the treatment of coronary artery disease: Clinical outcomes from randomized controlled trials.
    Rizik DG; Hermiller JB; Kereiakes DJ
    Catheter Cardiovasc Interv; 2016 Nov; 88(S1):21-30. PubMed ID: 27797464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A paradox in sex-specific clinical outcomes after bioresorbable scaffold implantation: 2-year results from the AIDA trial.
    Kerkmeijer LSM; Tijssen RYG; Hofma SH; Pinxterhuis TH; Kraak RP; Kalkman DN; van der Schaaf RJ; Arkenbout EK; Weevers APJD; Beijk MA; Baan J; Vis MM; Koch KT; Tijssen JGP; Piek JJ; Henriques JPS; de Winter RJ; Wykrzykowska JJ
    Int J Cardiol; 2020 Feb; 300():93-98. PubMed ID: 31511193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of BVS from a prospective multicenter registry: Impact of a dedicated implantation technique on clinical outcomes.
    Regazzoli D; Latib A; Ezhumalai B; Tanaka A; Leone PP; Khan S; Kumar V; Rastogi V; Ancona MB; Mangieri A; Giannini F; Mitomo S; Seth A; Colombo A
    Int J Cardiol; 2018 Nov; 270():113-117. PubMed ID: 29983253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of early clinical outcomes between ABSORB bioresorbable vascular scaffold and everolimus-eluting stent implantation in a real-world population.
    Costopoulos C; Latib A; Naganuma T; Miyazaki T; Sato K; Figini F; Sticchi A; Carlino M; Chieffo A; Montorfano M; Colombo A
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):E10-5. PubMed ID: 24909303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioresorbable vascular scaffolds: design, clinical trials, and current applications.
    Devito F; Zito A; Dachille A; Carbonara R; Giardinelli F; Bulzis G; Navarese EP; Scicchitano P; Gaglione A; Masi F; Ciccone MM
    Coron Artery Dis; 2016 Mar; 27(2):151-8. PubMed ID: 26717005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Looking into the future with bioresorbable vascular scaffolds.
    Costopoulos C; Naganuma T; Latib A; Colombo A
    Expert Rev Cardiovasc Ther; 2013 Oct; 11(10):1407-16. PubMed ID: 24138526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical coherence tomography guidance for percutaneous coronary intervention with bioresorbable scaffolds.
    Caiazzo G; Longo G; Giavarini A; Kilic ID; Fabris E; Serdoz R; Mattesini A; Foin N; Secco GG; De Rosa S; Indolfi C; Di Mario C
    Int J Cardiol; 2016 Oct; 221():352-8. PubMed ID: 27404705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical findings after bioresorbable vascular scaffold implantation in an unrestricted cohort of patients with ST-segment elevation myocardial infarction (from the RAI registry).
    Moscarella E; Ielasi A; Varricchio A; De Angelis MC; Loi B; Tarantini G; Calabrò P; Cortese B; Mazzarotto P; Gabrielli G; Pisano F; Facchin M; Misuraca L; Lucci V; Gistri R; Tumminello G; Moretti L; Colombo A; Durante A; Fineschi M; Piraino D; Ferrario M; Coscarelli S; Nicolino A; Tespili M; Corrado D; Steffenino G
    Int J Cardiol; 2018 May; 258():50-54. PubMed ID: 29429635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioresorbable Vascular Scaffold With Optimized Implantation Technique: Long-Term Outcomes From a Single-Center Experience.
    Albani S; Giannini F; Mitomo S; Fabris E; Mangieri A; Ponticelli F; Khokhar AA; Toselli M; Latib A; Colombo A
    J Invasive Cardiol; 2021 Feb; 33(2):E115-E122. PubMed ID: 33443487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procedural and clinical outcomes of the Absorb everolimus-eluting bioresorbable vascular scaffold: one-month results of the Bioresorbable vascular Scaffold Evaluated At Rotterdam Cardiology Hospitals (B-SEARCH).
    Simsek C; Magro M; Onuma Y; Boersma E; Smits P; Dorange C; Veldhof S; Regar E; Serruys PW; van Geuns RJ
    EuroIntervention; 2014 Jun; 10(2):236-40. PubMed ID: 23999210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Italian Diffuse/Multivessel Disease ABSORB Prospective Registry (IT-DISAPPEARS). Study design and rationale.
    Testa L; Biondi Zoccai G; Tomai F; Ribichini F; Indolfi C; Tamburino C; Bartorelli A; Petronio AS; Bedogni F; De Carlo M
    J Cardiovasc Med (Hagerstown); 2015 Mar; 16(3):253-8. PubMed ID: 25469734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of BVS implantation: a focus on safety and efficacy of the bioresorbable technology.
    DEN Dekker WK; VAN Geuns RJ; Diletti R
    Minerva Cardioangiol; 2016 Aug; 64(4):462-72. PubMed ID: 27175976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bioresorbable vascular scaffolds: clinical experience of the Emilia-Romagna Region, Italy].
    Menozzi A; Campo GC; Guiducci V; Dall'Ara G; Santarelli A; Sbarzaglia P; Balducelli M; Magnavacchi P; Sgura F; Losi L; Vignali L; Casella G; Steffanon L; Tarantino F; Saia F
    G Ital Cardiol (Rome); 2017 Feb; 18(2 Suppl 1):9S-18S. PubMed ID: 28398396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.